USD 0.01
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 723 Thousand USD | 484.57% |
2022 | -188 Thousand USD | -4600.0% |
2021 | -4000.00 USD | 99.85% |
2020 | -2.64 Million USD | 90.88% |
2019 | -28.98 Million USD | 0.0% |
2013 | 537 Thousand USD | 128.81% |
2012 | -1.86 Million USD | 73.84% |
2011 | -7.12 Million USD | -32.11% |
2010 | -5.39 Million USD | 38.04% |
2009 | -8.7 Million USD | -115.36% |
2008 | -4.04 Million USD | -261.86% |
2007 | -1.11 Million USD | -181.35% |
2006 | 1.37 Million USD | -74.31% |
2005 | 5.34 Million USD | -32.09% |
2004 | 7.87 Million USD | 51.19% |
2003 | 5.2 Million USD | 147.49% |
2002 | -10.96 Million USD | -992.03% |
2001 | 1.22 Million USD | 24.9% |
2000 | 984 Thousand USD | 64.0% |
1999 | 600 Thousand USD | 102.35% |
1998 | -25.5 Million USD | -628.57% |
1997 | -3.5 Million USD | -29.63% |
1996 | -2.7 Million USD | -140.91% |
1995 | 6.6 Million USD | -10.81% |
1994 | 7.4 Million USD | 57.45% |
1993 | 4.7 Million USD | 2.17% |
1992 | 4.6 Million USD | 6.98% |
1991 | 4.3 Million USD | 86.96% |
1990 | 2.3 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 98 Thousand USD | 0.0% |
2023 Q2 | 500 Thousand USD | 777.19% |
2023 Q1 | 57 Thousand USD | 0.0% |
2023 Q3 | - USD | -100.0% |
2023 FY | 723 Thousand USD | 484.57% |
2022 FY | -188 Thousand USD | -4600.0% |
2022 Q2 | -191 Thousand USD | -695.83% |
2022 Q1 | -24 Thousand USD | 0.0% |
2021 Q1 | 222 Thousand USD | 0.0% |
2021 FY | -4000.00 USD | 99.85% |
2021 Q2 | -88 Thousand USD | -139.64% |
2020 FY | -2.64 Million USD | 90.88% |
2019 FY | -28.98 Million USD | 0.0% |
2018 Q2 | 2.46 Million USD | 1969.75% |
2018 Q1 | 119 Thousand USD | 0.0% |
2018 Q3 | -1.13 Million USD | -146.08% |
2018 Q4 | -2.07 Million USD | -82.73% |
2017 Q3 | 7083.00 USD | 0.0% |
2016 Q3 | 26.00 USD | 0.0% |
2014 Q2 | 181 Thousand USD | 141.61% |
2014 Q1 | -435 Thousand USD | 0.0% |
2014 Q3 | -246 Thousand USD | -235.91% |
2013 Q3 | -343 Thousand USD | -346.76% |
2013 Q2 | 139 Thousand USD | -54.58% |
2013 Q1 | 306 Thousand USD | 30700.0% |
2013 FY | 537 Thousand USD | 128.81% |
2012 Q2 | 467 Thousand USD | 139.58% |
2012 Q4 | -1000.00 USD | -101.2% |
2012 FY | -1.86 Million USD | 73.84% |
2012 Q1 | -1.18 Million USD | -147.38% |
2012 Q3 | 83 Thousand USD | -82.23% |
2011 Q1 | -52 Thousand USD | 88.1% |
2011 FY | -7.12 Million USD | -32.11% |
2011 Q4 | -477 Thousand USD | 26.62% |
2011 Q3 | -650 Thousand USD | 87.6% |
2011 Q2 | -5.24 Million USD | -9984.62% |
2010 FY | -5.39 Million USD | 38.04% |
2010 Q3 | -1.39 Million USD | -6.91% |
2010 Q2 | -1.3 Million USD | 7.0% |
2010 Q1 | -1.4 Million USD | -24.31% |
2010 Q4 | -437 Thousand USD | 68.63% |
2009 Q2 | -4.5 Million USD | -49.04% |
2009 Q4 | -1.12 Million USD | 27.9% |
2009 Q3 | -1.56 Million USD | 65.32% |
2009 Q1 | -3.02 Million USD | -121.7% |
2009 FY | -8.7 Million USD | -115.36% |
2008 Q3 | 190 Thousand USD | 131.61% |
2008 Q2 | -601 Thousand USD | 84.06% |
2008 Q1 | -3.77 Million USD | -1572.66% |
2008 FY | -4.04 Million USD | -261.86% |
2008 Q4 | -1.36 Million USD | -817.89% |
2007 Q3 | 73 Thousand USD | 104.46% |
2007 Q2 | -1.63 Million USD | -4100.0% |
2007 Q4 | 256 Thousand USD | 250.68% |
2007 FY | -1.11 Million USD | -181.35% |
2007 Q1 | -39 Thousand USD | -117.11% |
2006 Q3 | 332 Thousand USD | 242.27% |
2006 FY | 1.37 Million USD | -74.31% |
2006 Q1 | 433 Thousand USD | -1.59% |
2006 Q2 | 97 Thousand USD | -77.6% |
2006 Q4 | 228 Thousand USD | -31.33% |
2005 FY | 5.34 Million USD | -32.09% |
2005 Q1 | 1.51 Million USD | -21.45% |
2005 Q2 | 433 Thousand USD | -71.44% |
2005 Q4 | 440 Thousand USD | 9.18% |
2005 Q3 | 403 Thousand USD | -6.93% |
2004 FY | 7.87 Million USD | 51.19% |
2004 Q4 | 1.93 Million USD | 31.65% |
2004 Q3 | 1.46 Million USD | -65.37% |
2004 Q2 | 4.23 Million USD | 203.01% |
2004 Q1 | 1.39 Million USD | 5.12% |
2003 Q4 | 1.32 Million USD | 45.72% |
2003 Q2 | 834 Thousand USD | 57.95% |
2003 Q1 | 528 Thousand USD | -63.54% |
2003 FY | 5.2 Million USD | 147.49% |
2003 Q3 | 912 Thousand USD | 9.35% |
2002 Q1 | 299 Thousand USD | -71.06% |
2002 Q2 | -14.39 Million USD | -4914.05% |
2002 Q3 | 2.4 Million USD | 116.69% |
2002 Q4 | 1.44 Million USD | -39.72% |
2002 FY | -10.96 Million USD | -992.03% |
2001 Q1 | -5.83 Million USD | -721.73% |
2001 Q3 | 2.11 Million USD | -52.51% |
2001 Q4 | 1.03 Million USD | -51.25% |
2001 FY | 1.22 Million USD | 24.9% |
2001 Q2 | 4.46 Million USD | 176.43% |
2000 Q1 | 3.41 Million USD | 1238.0% |
2000 Q4 | 939 Thousand USD | -43.6% |
2000 FY | 984 Thousand USD | 64.0% |
2000 Q2 | -2.39 Million USD | -170.04% |
2000 Q3 | 1.66 Million USD | 169.64% |
1999 Q3 | 300 Thousand USD | 200.0% |
1999 FY | 600 Thousand USD | 102.35% |
1999 Q4 | -300 Thousand USD | -200.0% |
1999 Q1 | 300 Thousand USD | 50.0% |
1999 Q2 | 100 Thousand USD | -66.67% |
1998 Q2 | -9.3 Million USD | -34.78% |
1998 Q3 | 100 Thousand USD | 101.08% |
1998 Q4 | 200 Thousand USD | 100.0% |
1998 FY | -25.5 Million USD | -628.57% |
1998 Q1 | -6.9 Million USD | 13.75% |
1997 Q2 | -4 Million USD | -1100.0% |
1997 FY | -3.5 Million USD | -29.63% |
1997 Q3 | -1.3 Million USD | 67.5% |
1997 Q1 | 400 Thousand USD | 300.0% |
1997 Q4 | -8 Million USD | -515.38% |
1996 FY | -2.7 Million USD | -140.91% |
1996 Q4 | 100 Thousand USD | -75.0% |
1996 Q3 | 400 Thousand USD | 140.0% |
1996 Q2 | -1 Million USD | -25.0% |
1996 Q1 | -800 Thousand USD | -157.14% |
1995 Q2 | -700 Thousand USD | -133.33% |
1995 FY | 6.6 Million USD | -10.81% |
1995 Q4 | 1.4 Million USD | 0.0% |
1995 Q3 | 1.4 Million USD | 300.0% |
1995 Q1 | 2.1 Million USD | -19.23% |
1994 Q2 | 2.5 Million USD | 56.25% |
1994 Q1 | 1.6 Million USD | 6.67% |
1994 FY | 7.4 Million USD | 57.45% |
1994 Q4 | 2.6 Million USD | 0.0% |
1994 Q3 | 2.6 Million USD | 4.0% |
1993 Q1 | 800 Thousand USD | -27.27% |
1993 FY | 4.7 Million USD | 2.17% |
1993 Q4 | 1.5 Million USD | -16.67% |
1993 Q3 | 1.8 Million USD | 20.0% |
1993 Q2 | 1.5 Million USD | 87.5% |
1992 Q1 | 1.4 Million USD | 27.27% |
1992 Q2 | 900 Thousand USD | -35.71% |
1992 Q3 | 1.3 Million USD | 44.44% |
1992 FY | 4.6 Million USD | 6.98% |
1992 Q4 | 1.1 Million USD | -15.38% |
1991 Q3 | 1.2 Million USD | 0.0% |
1991 Q1 | 1 Million USD | 0.0% |
1991 Q2 | 1.2 Million USD | 20.0% |
1991 FY | 4.3 Million USD | 86.96% |
1991 Q4 | 1.1 Million USD | -8.33% |
1990 FY | 2.3 Million USD | 0.0% |
1990 Q2 | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1990 Q1 | - USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1989 Q3 | - USD | 0.0% |
1989 Q4 | - USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | -722.81 Thousand USD | 200.026% |
IR-Med Inc. | -4.9 Million USD | 114.728% |
Polarean Imaging plc | -11.88 Million USD | 106.083% |
Medical Supply International USA, Inc. | 394.84 Thousand USD | -83.112% |
Avitar, Inc. | -2.25 Million USD | 131.996% |
AVITA Medical, Inc. | -39.16 Million USD | 101.846% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 162.06% |
Össur hf. | 58.38 Million USD | 98.762% |
Zecotek Photonics Inc. | -3.51 Million USD | 120.546% |
QHSLab, Inc. | -468.36 Thousand USD | 254.368% |
Wellstar International, Inc. | -3.1 Million USD | 123.259% |
Össur hf. | 58.38 Million USD | 98.762% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 2.35 Million USD | 69.26% |
Escalon Medical Corp. | -125.26 Thousand USD | 677.195% |
Aurora Spine Corporation | -1.68 Million USD | 143.021% |
BrainsWay Ltd. | -4.19 Million USD | 117.227% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | -11.49 Million USD | 106.289% |
Hamilton Thorne Ltd. | -607.02 Thousand USD | 219.106% |
Vivos Inc. | -2.89 Million USD | 124.976% |
MicroPort Scientific Corporation | -477.62 Million USD | 100.151% |
Kelyniam Global, Inc. | -218.47 Thousand USD | 430.936% |
REMSleep Holdings, Inc. | -1.77 Million USD | 140.667% |
CYduct Diagnostics, Inc. | -418.03 Thousand USD | 272.953% |
Nanomix Corporation | -12.33 Million USD | 105.862% |
Theraclion SA | -3.67 Million USD | 119.673% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | -752.98 Thousand USD | 196.018% |
Positron Corporation | -1.63 Million USD | 144.12% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | -2.64 Million USD | 127.373% |
Lombard Medical, Inc. | -31.03 Million USD | 102.33% |
ALR Technologies Inc. | -11.89 Million USD | 106.077% |
Stratec SE | 14.42 Million USD | 94.988% |
Vycor Medical, Inc. | -69.69 Thousand USD | 1137.437% |
Heart Tronics, Inc. | -13.32 Million USD | 105.425% |
Nu-Med Plus, Inc. | -125.52 Thousand USD | 675.976% |
Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 105.151% |
SANUWAVE Health, Inc. | -25.8 Million USD | 102.802% |
VMS Rehab Systems, Inc. | 46.44 USD | -1556747.545% |
Guided Therapeutics, Inc. | -3.48 Million USD | 120.722% |
Ingen Technologies, Inc. | -5.06 Million USD | 114.284% |
Odyssey Group International, Inc. | -905.77 Thousand USD | 179.822% |
ECGI Holdings, Inc. | -3.61 Million USD | 120.023% |
Capital Group Holdings, Inc. | -658.02 Thousand USD | 209.874% |
ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 200.858% |
Urologix, Inc. | -7.6 Million USD | 109.503% |
Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 142.685% |
Nexeon MedSystems Inc. | -2.17 Million USD | 133.201% |
SS Innovations International, Inc. | -20.94 Million USD | 103.452% |
Qualis Innovations, Inc. | -805.02 Thousand USD | 189.811% |
Smith & Nephew plc | 263 Million USD | 99.725% |
NIOX Group Plc | 13.64 Million USD | 94.7% |
Fuse Medical, Inc. | 1.45 Million USD | 50.478% |
Broncus Holding Corporation | -28.09 Million USD | 102.574% |
Brain Scientific Inc. | -12.34 Million USD | 105.857% |
Pressure BioSciences, Inc. | -29.31 Million USD | 102.466% |
Health Logic Interactive Inc. | -160.24 Thousand USD | 551.176% |